| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/13/2008 | EP1956000A1 Acylating agents useful for acylating peptides |
| 08/13/2008 | EP1954675A1 Method of preparation of maleimides by thermal cyclization of maleamic acids in the presence of a catalyst |
| 08/13/2008 | EP1954674A1 New n-phenethylcarboxamide derivatives |
| 08/13/2008 | EP1620394B1 Method for crystallizing guanidinium salts |
| 08/13/2008 | EP1572632B1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | EP1420782B1 Use of nefiracetam for treating post-stroke neurodegeneration |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | EP0934924B1 Novel diamide compounds and drugs containing the same |
| 08/13/2008 | CN101243067A Novel anthranilamides for controlling invertebrate pests |
| 08/13/2008 | CN101239940A Method for preparing 1,4-di(2,4-dimaleimidophenoxy)benzene |
| 08/13/2008 | CN101239939A Chirality five-membered heterocyclic compound and high enantioselectivity preparation method thereof |
| 08/13/2008 | CN101239938A Method for preparing (S)-4-hydroxypyrrolidone and derivatives thereof |
| 08/13/2008 | CN101239937A Method for preparing optical activity R-(-)-1-benzylcarbonyl-3-aminopyrrolidine and hydrochloride thereof |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/13/2008 | CN100409844C Noval compound, its synthetizing process and therapeutic use |
| 08/12/2008 | US7411093 e.g. 2-(2-methoxy-phenyl)-cyclohexylamine; dipeptidyl-peptidase inhibitor; antidiabetic agent; non-insulin dependent diabetes mellitus, and impaired glucose tolerance, obesity, metabolic syndrome or beta -cell protection |
| 08/12/2008 | US7411091 e.g. N-2- (4-Butyloxy-benzylamino)-ethyl-acetamide; sodium or calcium channel modulators; neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urologic, metabolic and gastrointestinal diseases |
| 08/12/2008 | US7411075 Polymorphic form of atorvastatin calcium |
| 08/12/2008 | US7410999 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 08/12/2008 | US7410995 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders |
| 08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
| 08/12/2008 | CA2432704C Hydroxy aromatic mannich base condensation products and the use thereof as soot dispersants in lubricating oil compositions |
| 08/12/2008 | CA2322158C Arylphenyl-substituted cyclic keto-enols |
| 08/07/2008 | WO2008095069A2 High stability polyionic liquid salts |
| 08/07/2008 | WO2008095064A2 High stability diionic liquid salts |
| 08/07/2008 | WO2008093951A1 Atorvastatin strontium salt and pharmaceutical composition comprising same |
| 08/07/2008 | WO2008093737A1 Amide derivative |
| 08/07/2008 | WO2007111948A3 Inhibitors of protein prenyltransferases |
| 08/07/2008 | WO2007108999A3 Production of 2,5-dihydrofurans and analogous compounds |
| 08/07/2008 | US20080188669 Novel mixture and compounds from mycelia of Antrodia camphorata and use thereof |
| 08/07/2008 | US20080188652 Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid |
| 08/07/2008 | US20080188547 Uses of ion channel modulating compounds |
| 08/07/2008 | US20080188546 Preventive or therapeutic agents for decubitus |
| 08/07/2008 | US20080188545 (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride monohydrate; cardiovascular disease; osteoporosis; inflammation of airway epithelium; disorders of alveolar tissue; bladder incontinence; impaired hearing; endothelial lesions |
| 08/07/2008 | US20080188520 e.g. 1-(2-Cyclopropylmethoxy-1,2-diphenylethyl)-1H-pyridin-2-one; potassium (K+) channel-blocking agent; potassium channel KACh and TASK-1 channel blocking agent; atrial arrhythmias, atrial fibrillation or atrial flutter; respiratory disorders, neurodegenerative disorders; anticarcinogenic agent |
| 08/07/2008 | US20080188489 Cell differentiation inducer |
| 08/07/2008 | US20080188453 Mapk/erk kinase inhibitors |
| 08/07/2008 | US20080188423 Pi-3 kinase inhibitor prodrugs |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | CA2675996A1 Atorvastatin strontium salt and pharmaceutical composition comprising same |
| 08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
| 08/06/2008 | EP1951702A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| 08/06/2008 | EP1951700A2 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
| 08/06/2008 | EP1951684A1 Bi-aryl meta-pyrimidine inhibitors of kinases |
| 08/06/2008 | EP1951667A2 Thrombopoietin activity modulating compounds and methods |
| 08/06/2008 | EP1951666A2 Pyroglutamic acid esters with improved biodegradability |
| 08/06/2008 | EP1951665A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof |
| 08/06/2008 | EP1951660A1 Histamine-3 receptor antagonists |
| 08/06/2008 | EP1951250A2 Chemical compounds |
| 08/06/2008 | EP1773768A4 Pyrrole derivatives as pharmaceutical agents |
| 08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | CN101238099A Salts of vildagliptin |
| 08/06/2008 | CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 08/06/2008 | CN100408552C Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production |
| 08/06/2008 | CN100408539C Vitamin d receptor modulators |
| 08/05/2008 | US7408071 N-aryl pyrrolidine derivatives as beta-secretase inhibitors |
| 08/05/2008 | US7408067 Neuregulins such as 4-(4-Hydroxyphenylthio)-piperidine trifluoroacetate for treatment of dysfunctions of central and autonomic nervous systems |
| 08/05/2008 | US7408008 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407648 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine |
| 08/05/2008 | CA2505968C Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 08/05/2008 | CA2426632C Atorvastatin hemi-calcium form vii |
| 08/05/2008 | CA2337098C Anthranilic acid derivatives |
| 08/05/2008 | CA2224435C Pyrrolopyrimidines and processes for the preparation thereof |
| 07/31/2008 | WO2008092168A2 Methods for the preparation of imides, maleimides and maleimide-terminated polyimide compounds |
| 07/31/2008 | WO2008090819A1 Process for production of bicyclic proline compound |
| 07/31/2008 | WO2008089557A1 Atorvastatin calcium propylene glycol solvates |
| 07/31/2008 | WO2008068423A3 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 07/31/2008 | WO2008057775A3 Heterocyclic amide compounds useful as kinase inhibitors |
| 07/31/2008 | WO2008054605A3 Non-nucleoside reverse transcriptase inhibitors |
| 07/31/2008 | WO2008027273A3 Solid citrate and tartrate salts of dpp-iv inhibitors |
| 07/31/2008 | US20080182995 Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-iv |
| 07/31/2008 | US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine |
| 07/31/2008 | US20080182889 Prodrugs of excitatory amino acids |
| 07/31/2008 | US20080182888 Novel Crystalline Compounds |
| 07/31/2008 | US20080182876 Histamine H3-Receptor Ligands and Their Therapeutic Application |
| 07/31/2008 | US20080182798 Novel effectors of dipeptidyl peptidase IV |
| 07/31/2008 | US20080179565 Photosensitive monomer, liquid crystal material having the same, liquid crystal panel and method for manufacturing thereof by incorporating the same, and electro-optical device and method for manufacturing thereof by incorporating the same |
| 07/31/2008 | US20080178763 exhibit high fluorescence in inks; useful for security taggant applications |
| 07/31/2008 | DE102007047229A1 Verzweigte Succinimid-Dispergiermittelverbindungen und Verfahren zur Herstellung der Verbindungen Branched succinimide dispersant compounds and methods for preparing the compounds |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1950198A1 Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative |
| 07/30/2008 | EP1948643A2 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 07/30/2008 | EP1948629A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 07/30/2008 | EP1948599A1 Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
| 07/30/2008 | EP1948598A1 Process for preparation of (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt |
| 07/30/2008 | EP1948597A1 Derivatives for modulation of ion channels |
| 07/30/2008 | EP1948596A2 Soft anticholinergic esters |
| 07/30/2008 | EP1948184A2 Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis |
| 07/30/2008 | EP1685103B1 3-aminopyrrolidone derivatives |
| 07/30/2008 | EP1660447B1 Cyclic amine bace-1 inhibitors having a heterocyclic substituent |
| 07/30/2008 | CN101233104A Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 07/30/2008 | CN101233103A Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406438C Preparation method of amorphous atorvastatin calcium |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |